Accuneb Related Published Studies
Well-designed clinical trials related to Accuneb (Albuterol Inhalation)
Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction. [2011.07]
Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. [2010.08]
Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial. [2010.03]
Beneficial effects of warmed humidified oxygen combined with nebulized albuterol and ipratropium in pediatric patients with acute exacerbation of asthma in winter months. [2009.11]
Bronchodilator effects of exercise hyperpnea and albuterol in mild-to-moderate asthma. [2009.08]
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. [2008.09]
Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations. [2008.07]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Comparison of nebulized epinephrine to albuterol in bronchiolitis. [2008.04]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2008]
Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. [2007.12]
An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. [2007.11]
Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis. [2007.06.02]
Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. [2007.06]
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. [2007.05.17]
Effect of albuterol on maximal exercise capacity in cystic fibrosis. [2007.04]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2007.01.25]
Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma. [2007]
Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial. [2006.06]
A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. [2006.05]
Assessing the Effects of Racemic and Single-Enantiomer Albuterol on Airway Secretions in Long-term Intubated Patients. [2006.01]
Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial. [2006.01]
Randomized, placebo-controlled trial of albuterol and epinephrine at equipotent beta-2 agonist doses in acute bronchiolitis. [2005.10]
Regular vs ad-lib albuterol for patients hospitalized with acute asthma. [2005.09]
Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation. [2005.09]
Effect of nebulized albuterol on blood glucose in patients with diabetes mellitus with and without cystic fibrosis. [2005.08]
Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. [2005.07]
Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial. [2005.07]
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. [2005.05]
The study of in vitro-in vivo correlation: pharmacokinetics and pharmacodynamics of albuterol dry powder inhalers. [2005.01]
Comparison of the bronchodilating effects of formoterol and albuterol delivered by hydrofluoroalkane pressurized metered-dose inhaler. [2005]
Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma. [2004.11]
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. [2004.10.23]
Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. [2004.10]
Comparison of nebulized magnesium sulfate plus albuterol to nebulized albuterol plus saline in children with acute exacerbations of mild to moderate asthma. [2004.07]
Response to inhaled albuterol during nocturnal asthma. [2004.06]
A randomized trial of nebulized epinephrine vs albuterol in the emergency department treatment of bronchiolitis. [2004.02]
A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD. [2004]
An evaluation of nebulized levalbuterol in stable COPD. [2003.09]
Comparison of two forms of albuterol for treatment of acute bronchospasm in pediatric patients. [2003.05]
Addition of ipratropium to nebulized albuterol in children with acute asthma presenting to a pediatric office. [2003.03]
Formoterol delivered via the dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a randomized, double-blind, double-dummy trial. [2003]
Efficacy response of inhaled HFA-albuterol delivered via the breath-actuated Autohaler inhalation device is comparable to dose in patients with asthma. [2003]
A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol. [2002.12]
A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered- dose inhalers. [2002.11]
The effects of inhaled albuterol and salmeterol in 2- to 5-year-old asthmatic children as measured by impulse oscillometry. [2002.09]
Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients. [2002.07]
Efficacy of albuterol inhalation in treatment of hyperkalemia in premature neonates. [2002.07]
A randomized clinical trial of nebulized magnesium sulfate in addition to albuterol in the treatment of acute mild-to-moderate asthma exacerbations in adults. [2002.06]
The utility of albuterol nebulized with heliox during acute asthma exacerbations. [2002.05.01]
Furosemide plus albuterol compared with albuterol alone in children with acute asthma. [2002.05]
A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients. [2002.05]
Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction. [2002.05]
Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. [2001.12]
Standard dose of inhaled albuterol significantly increases QT dispersion compared to low dose of albuterol plus ipratropium bromide therapy in moderate to severe acute asthma attacks in children. [2001.12]
A prospective controlled trial of albuterol aerosol delivered via metered dose inhaler-spacer device (MDI) versus jet nebulizer in ventilated preterm neonates. [2001.05]
A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler. [2001.01]
Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. [2001.01]
Inhaled albuterol, but not intravenous lidocaine, protects against intubation-induced bronchoconstriction in asthma. [2000.11]
Chronic effects of inhaled albuterol on beta-adrenoceptor system function in human respiratory cells. [2000.06]
Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration. [2000.01]
Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease? [1999.12]
Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol. [1999.10]
Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. [1999.09]
Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma. [1999.08]
Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma. [1999.04]
Safety of long-term treatment with HFA albuterol. [1999.04]
Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial. [1999.04]
The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. [1999.04]
Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol. [1999.02]
Comparative efficacy and safety of albuterol sulfate Spiros inhaler and albuterol metered-dose inhaler in asthma. [1999.02]
For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base. [1999.01.25]
Comparison of 2.5 vs 7.5 mg of inhaled albuterol in the treatment of acute asthma. [1999.01]
A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol. [1999.01]
Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers. [1998.12]
A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis. [1998.01]
Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group. [1998]
Effects of inhaled salmeterol and salbutamol (albuterol) on morning dips compared in intensive care patients recovering from an acute severe asthma attack. [1997.12]
Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. [1997.12]
Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler. [1997.10]
Efficacy of metered-dose inhaler administration of albuterol in intubated infants. [1997.08]
Emergency treatment of acute asthma with albuterol metered-dose inhaler plus holding chamber: how often should treatments be administered? [1997.08]
Reduction in post-intubation respiratory resistance by isoflurane and albuterol. [1997.07]
Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. [1997.07]
Effects of inhaled albuterol and ipratropium bromide on autonomic control of the cardiovascular system. [1997.06]
Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. [1996.09.19]
Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma. [1996.09]
The effect of inhaled albuterol in moderate to severe asthma. [1996.08]
The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis. [1996.07]
Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol. [1996.04]
Isoetharine versus albuterol for acute asthma: greater immediate effect, but more side effects. [1996.03]
The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. [1996.01]
Terbutaline vs albuterol for out-of-hospital respiratory distress: randomized, double-blind trial. [1995.08]
Regular use of inhaled albuterol and the allergen-induced late asthmatic response. [1995.07]
Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids. [1995.07]
Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. [1995.06]
The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. [1995.06]
The effects of albuterol on power output in non-asthmatic athletes. [1995.05]
Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of chronic obstructive pulmonary disease. [1995.04]
Dry powder inhalers are bioequivalent to metered-dose inhalers. A study using a new urinary albuterol (salbutamol) assay technique. [1995.03]
Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol. [1995.02]
|
